Method of treating polycythemia vera

Details Method of treating polycythemia vera Method of treating polycythemia vera

2006-08-22

2006-08-22

Low, Christopher S. F. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S252140, C514S252180, C514S256000

Reexamination Certificate

active

07094785

ABSTRACT:
The invention is directed to the use of imatinib mesylate for treating polycythemia vera. Imatinib mesylate is surprisingly effective at controlling the symptoms of polycythemia vera and reducing the need for phlebotomy.

REFERENCES:
patent: 4041842 (1977-08-01), Stunkel
patent: 4140122 (1979-02-01), Kuhl et al.
patent: 4383529 (1983-05-01), Webster
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 5093330 (1992-03-01), Caravatti et al.
patent: 5450856 (1995-09-01), Norris
patent: 2003/0086924 (2003-05-01), Sliwkowski
patent: 2004/0087546 (2004-05-01), Zeldis
patent: 0564409 (1993-10-01), None
patent: WO-9407529 (1994-04-01), None
patent: WO-9835958 (1998-08-01), None
patent: WO-9903854 (1999-01-01), None
patent: 03090750 (2003-11-01), None
Remington: The Science and Practice of Pharmacy, Mack Publishing Co.,Nineteenth Edition, vol. 1, (1995), Chapter 48, “The Introduction of New Drugs”, pp. 795-808.

Affiliated with

Also associated with

Rating

Method of treating polycythemia vera does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating polycythemia vera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating polycythemia vera will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3647893